Concepedia

Ulrich Niewöhner

UN

Statistics

Publications

7

Citations

1.1K

H-Index

7

Active since

1981

Affiliations

Bayer (Germany)(Current)

Ulrich Niewöhner is an author at Bayer (Germany) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1981–2005

7

Publications

7

Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids

Karl Deres, Claus H. Schröder, Arnold Paessens et al. · Science · 2003 · 506 citations

, , +17

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

I Sáenz de Tejada, Javier Angulo, Pedro Cuevas et al. · International Journal of Impotence Research · 2001 · 231 citations

, , +13

Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat

Jos Prickaerts, Wilma C.G. van Staveren, M. Markerink–van Ittersum et al. · Neuroscience · 2002 · 229 citations

, , +16

Imidazo[5,1-f][1,2,4]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors

Helmut Haning, Ulrich Niewöhner, Thomas Schenke et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 75 citations · Full text

, , +7

Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitors

Helmut Haning, Ulrich Niewöhner, Thomas Schenke et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 43 citations · Full text

, , +12

1–5 of 7